Clarify Atlas Platform
The data foundation powering referral network optimization with 300M+ patient lives and 5.6T price transparency rates
Company profile
Company profile
Clarify Health Solutions is a healthcare outcomes company that partners with over 60 health systems to transform referral management and network performance. The company's flagship product, Clarify Meridian, is the first platform to unify referral intelligence, physician activation, consumer engagement, and outcomes attribution into a single system. Built on the Clarify Atlas Platform, which contains over 300 million patient lives and 5.6 trillion price transparency rates, Meridian helps health systems address the trillion-dollar blind spot in referral decisions. The platform enables health systems to identify which referrals to optimize, which specialists deliver the best outcomes for each contract, and what the financial impact looks like before any action is taken. Clarify operates as a tech-enabled outcomes partnership, deploying both the platform and dedicated Success Services teams directly into health system operations, with economics tied to measurable results. The company has documented $3.2 billion in customer ROI and helps health systems capture $65-100 million in annual opportunity per organization. Clarify's mission is to prove that the care that is best for patients is also the care that makes the system sustainable, making mission and margin the same priority rather than competing objectives.
Company description Clarify Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Cloud Saas deployment with recorded integration context.
Company milestones
Acquired Loyal Health to create healthcare's first closed-loop network intelligence and patient activation platform. Platform now covers 300+ million patient lives and 5.6 trillion price transparency rates.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
The data foundation powering referral network optimization with 300M+ patient lives and 5.6T price transparency rates
Healthcare's first closed-loop network intelligence and patient activation platform for referral optimization
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Future oncology (London, England) · May 1, 2026
Endovascular abdominal aortic aneurysm repair (EVAR) outcomes of unibody and single/double docking limb endografts in Medicare beneficiaries between 2012 and 2018.Vascular · Dec 1, 2025
Trends in diagnostic testing in Medicare patients with wild-type transthyretin amyloid cardiomyopathy.Frontiers in cardiovascular medicine · Jan 1, 2025
Adherence and persistence to tafamidis treatment among Medicare beneficiaries in the presence of a patient assistance program.Scientific reports · Jul 15, 2024
Transforming Neurology Care Delivery Through a Population Health Data Strategy.Neurology. Clinical practice · Apr 1, 2024
Risk of mortality in older adults with loss of appetite: An analysis of Medicare fee-for-service data.The journal of nutrition, health & aging · Mar 1, 2024
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Across all customer partnerships
Gap between current performance and full potential for typical large health system
Addressable opportunity for referral optimization
Industry baseline showing opportunity for improvement
At large health systems, representing revenue loss
Referral network optimization to reduce leakage, strengthen referral performance, and capture more value from networks across 900 million annual referrals and $1 trillion in downstream spending
$3.2B documented customer ROI; $65-100M annual opportunity per health system; 60K+ cases lost to leakage recaptured per health system annually
05 · Leadership
Leadership profiles and professional links from the current Company record.
Todd Gottula
CEO and Co-Founder
Eliza Adams
Chief Operating Officer
Walker Hale
Chief Revenue Officer
John Barzydlo
Chief Customer Officer
Christine Gu
Chief Financial Officer
Justin Warner
Chief Technology Officer
Sabrina Poon
Chief Medical Officer
Erik Talvola
Chief AI & Privacy Officer
06 · Company updates
Recent articles published on Clarify Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered analytics for population health management, healthcare data integration and analysis, risk stratification, care gap identification, or value-based care analytics. Focuses on analyzing data across patient populations to improve outcomes at scale and enable data-driven decision-making across health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.